Abstract: An adhesive composition which contains a vinyl polymer and an acrylic adhesive polymer, and wherein: the vinyl polymer has a glass transition temperature (Tg) of from 60° C. to 200° C. (inclusive) and a number-average molecular weight of from 500 to 10,000; and the vinyl polymer is contained in an amount of from 0.5 part by mass to 60 parts by mass per 100 parts by mass of the acrylic adhesive polymer. If this adhesive composition is applied to a separator and then dried, thereby obtaining an adhesive layer, a first Tg that is the glass transition temperature of the entire adhesive layer is from ?80° C. to 10° C., and a second Tg that is the glass transition temperature calculated from a surface layer portion of the adhesive layer as determined by X-ray photoelectron spectroscopy is 40° C. or higher, and is higher than the first Tg by 30° C. or more.

Abstract: Provided is a method for producing myocardial cells from pluripotent stem cells. The myocardial cell production method provided by the present invention includes supplying an artificially produced synthetic peptide to a cell culture that contains pluripotent stem cells. The synthetic peptide is a peptide that contains a myocardial cell differentiation-inducing peptide sequence that induces pluripotent stem cells into myocardial cells. The myocardial cell differentiation-inducing peptide sequence is an amino acid sequence selected from the group consisting of (i) an amino acid sequence constituting the signal peptide of any protein belonging to the amyloid precursor protein (APP) family, (ii) a partial amino acid sequence of the amino acid sequence according to (i), and (iii) a modified amino acid sequence from the amino acid sequence according to (i) or (ii).

Abstract: Provide is an artificially synthesized antitumor peptide that may suppress proliferation of tumor cells. The peptide provided is a synthetic peptide that contains both (1) an amino acid sequence that forms a signal peptide of a membrane protein, programmed cell death-1 (PD-1), or a modified amino acid sequence thereof in which 1, 2 or 3 amino acid residues deleted from, substituted in or added to the above amino acid sequence; and (2) an amino acid sequence that serves as a cell penetrating peptide (CPP), and wherein the synthetic peptide comprises a total of 100 or fewer amino acid residues.

Abstract: The antitumor peptide provided by the present invention is a synthetic peptide including both of: (1) an amino acid sequence composing the second transmembrane region from the N-terminal of a membrane protein sphingosine 1-phosphate receptor 1 (S1PR1), or a modified amino acid sequence formed by deletion substitution or addition of 1, 2 or 3 amino acid residues in the amino acid sequence; and (2) an amino acid sequence functioning as a cell-penetrating peptide (CPP); wherein the total number of amino acid residues is 100 or less.

Abstract: The method for aiding ALS detection provided by the present invention includes determining a profile of signal peptides contained in a bodily fluid from a test subject, and comparing the signal peptide profile thus determined for the test subject with a previously-determined profile of signal peptides in a bodily fluid from a healthy subject. The presence of a difference between the signal peptide profile of the test subject and the signal peptide profile of the healthy subject at a specific molecular weight is then associated with the test subject's suffering from or developing ALS.

Abstract: This method for aiding Alzheimer's detection provided by the present invention includes: determining a profile of signal peptides contained in a bodily fluid from a test subject, and comparing the signal peptide profile thus determined for the test subject with a previously-determined profile of signal peptides in a bodily fluid from a healthy subject. A difference between the signal peptide profile of the test subject and the signal peptide profile of the healthy subject at a specific molecular weight is then associated with the test subject's suffering from or developing Alzheimer's.

Abstract: Apparatus for producing alkali hydroxide and method for operating apparatus for producing alkali hydroxide are provided. A cooling chamber through which a coolant can pass is constructed by placing a separation wall in a cathode chamber on a side opposite to an ion-exchange membrane, and a flow rate adjuster, such as manual valves, which can adjust the supply flow rate of the coolant is placed in each unit cell. The electrolytic temperature of each unit cell is regulated at an optimum operating temperature depending on the current density by adjusting the flow rate of the coolant without individually adjusting the flow rate of salt water supplied to the unit cell or the concentration of the salt water.

Abstract: A binder for secondary battery electrodes, which enables the achievement of a secondary battery electrode that has higher binding properties than ever before contains a block polymer that has a polymer block (A) and a polymer block (B), and it is configured such that: the polymer block (A) includes less than 30% by mass of a structural unit derived from (meth)acrylic acid to a total structural units of the polymer block (A); and the polymer block (B) includes 30 mass % or more and 100 mass % or less of a structural unit derived from (meth)acrylic acid to a total structural units of the polymer block (B).

Abstract: The present deodorant-containing processing liquid includes an acid salt of an aminoguanidine, an inorganic carrier capable of carrying the acid salt of the aminoguanidine, a dispersant, and water, a content of the acid salt of the aminoguanidine is 15 parts or more by mass based on 100 parts by mass of a content of the inorganic carrier, and the dispersant is at least one selected from a group consisting of an anionic surfactant and a nonionic surfactant.

Abstract: The method of producing induced lightweight exosomes (iLE) provided by the present invention includes preparing a cell culture containing prescribed cultured cells; supplying at least once an artificially produced synthetic peptide to the cell culture and culturing the cell culture for a prescribed interval; and obtaining exosomes produced by the cultured cells following culturing. Here, the synthetic peptide is provided with: (1) an exosome-inducing peptide sequence and (2) a CPP sequence, and has a total number of amino acid residues of 100 or less.

Abstract: A binder is for a secondary battery electrode and exhibits high binding properties in an electrode mixture layer and is capable of exhibiting superior cycle characteristics than before. This binder for a secondary battery electrode includes a cross-linked polymer or salt thereof, and the cross-linked polymer or salt thereof has a sol fraction of 5.0 mass % or more and 40 mass % or less. The cross-linked polymer or salt thereof may contain 50 mass % or more and 100 mass % or less of structural units derived from an ethylenic unsaturated carboxylic acid monomer.

Abstract: A semiconductor cleaning agent containing a sulfonic acid group-containing polymer, wherein a content of at least one metal selected from the group consisting of Na, Al, K, Ca and Fe is 0.7 ppm or less.

Abstract: A method for manufacturing polymer fine particles having a narrow particle diameter distribution without any particular limitations on the raw materials and the like. To achieve this purpose, this method for manufacturing polymer fine particles includes polymerizing a vinyl monomer using a dispersion polymerization method, wherein the amount of water in the reaction liquid in the polymerizing is no more than 30,000 ppm, the reactor for carrying out the polymerizing is a stirring tank reactor, the stirring blade attached to the stirring rotation shaft of the stirring tank reactor is one type selected from a large wide blade and a large lattice blade, and the tip speed of the stirring blade is no more than 1.0 m/sec.

Abstract: A secondary battery electrode has excellent characteristics. As a binder for a secondary battery electrode, a crosslinked polymer or salt thereof having a carboxyl group is used. The crosslinked polymer or salt includes 30 mass % or more and not more than 100 mass % of a structural unit derived from an ethylenically unsaturated carboxylic acid monomer and a metal ion content of the crosslinked polymer or salt thereof is not more than 100 ppm or less.

Abstract: An object of the present invention is to provide an antiviral agent suitable for inactivating a non-enveloped virus, a composition containing thereof, an antiviral product, and a method for producing the same. The antiviral agent against a non-enveloped virus includes at least one selected from a group consisting of (A) a compound containing Al element, Mg element, and O element; (B) a compound containing an alkali metal element or an alkaline earth metal element, Si element, and O element; and (C) a hydroxide containing a divalent metal element.

Abstract: A deodorant composition may be suitable for use with an aldehyde gas or a ketone gas, and may include an aminoguanidine salt and a metal chelating agent. The aminoguanidine salt is preferably at least one of an aminoguanidine hydrochloride and an aminoguanidine sulfate. The chelating agent is preferably at least one of an inorganic phosphoric acid and salt thereof, and a carboxylic acid and salt thereof.

Abstract: An active energy ray-curable composition is disclosed including: an anionically polymerizable compound represented by (1): wherein EWG represents an electron-withdrawing group, X represents a single bond or an oxygen atom (—O—), R represents an n-valent organic group, and n represents an integer of 1 to 6; when n is an integer of 2 to 6, the respective EWG and the respective X may be the same or different; and when n is 1, EWG and R may be bonded; and a compound (photobase generator) represented by (2): wherein ring A represents an aromatic ring that may be substituted or a heteroaromatic ring that may be substituted; R1 and R2 are the same or different and each represents a hydrogen atom or an alkyl group; R1 and R2 may be bonded to each other to form a ring together with an adjacent nitrogen atom; and the ring may be substituted.

Abstract: A binder for a nonaqueous electrolyte secondary battery electrode and use thereof are described. The binder contains a crosslinked polymer or salt thereof, the crosslinked polymer having an ethylenically unsaturated carboxylic acid and a crosslinkable monomer in constituent monomers thereof, or salt thereof, wherein the crosslinked polymer includes the ethylenically unsaturated carboxylic acid in an amount of 20 to 99.95 mass % of the total constituent monomers, and the crosslinked polymer includes at least one compound selected from the group made of trimethylolpropane diallyl ether and trimethylolpropane triallyl ether as the crosslinkable monomer.

Abstract: An antiviral peptide provided according to the present invention includes (1) an amino acid sequence (TM sequence) constituting a transmembrane region of G protein of vesicular stomatitis virus (VSV) or a modified amino acid sequence formed by conservative substitutions of 1, 2, or 3 amino acid residues in the TM sequence; and (2) an amino acid sequence (CPP sequence) functioning as a cell penetrating peptide (CPP), wherein a total number of amino acid residues is 100 or less.

Abstract: An object of the present invention is to provide a method for producing a coated material by using a composition that can be spray-coated, and that does not run downward after coating (i.e., rheology controllable). The method for producing a coated material includes step (1) of applying an electron beam-curable composition containing an ethylenically unsaturated group-containing compound to a substrate to form a coating film that has a surface viscosity of 1 Pa·s to 300 Pa·s as measured based on an electric-field pickup method, step (2) of drying the coating film obtained in step (1) to form a dry coating film when the electron beam-curable composition contains a volatile component, and step (3) of irradiating the substrate that has the coating film obtained in step (1) or the dry coating film obtained in step (2) with electron beams in an inert gas atmosphere to form a cured coating film.